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Abstract
Background: Assessment of human exposure to non-persistent pesticides such as pyrethroids is
often based on urinary biomarker measurements. Urinary metabolite levels of these pesticides are
usually reported in volume-weighted concentrations or creatinine-adjusted concentrations
measured in spot urine samples. It is known that these units are subject to intra- and inter-individual
variations. This research aimed at studying the impact of these variations on the assessment of
pyrethroid absorbed doses at individual and population levels.
Methods: Using data obtained from various adult and infantile populations, the intra and inter-
individual variability in the urinary flow rate and creatinine excretion rate was first estimated.
Individual absorbed doses were then calculated using volume-weighted or creatinine-adjusted
concentrations according to published approaches and compared to those estimated from the
amounts of biomarkers excreted in 15- or 24-h urine collections, the latter serving as a benchmark
unit. The effect of the units of measurements (volume-weighted or creatinine adjusted
concentrations or 24-h amounts) on results of the comparison of pyrethroid biomarker levels
between two populations was also evaluated.
Results: Estimation of daily absorbed doses of permethrin from volume-weighted or creatinine-
adjusted concentrations of biomarkers was found to potentially lead to substantial under or
overestimation when compared to doses reconstructed directly from amounts excreted in urine
during a given period of time (-70 to +573% and -83 to +167%, respectively). It was also shown that
the variability in creatinine excretion rate and urinary flow rate may introduce a bias in the case of
between population comparisons.
Conclusion:  The unit chosen to express biomonitoring data may influence the validity of
estimated individual absorbed dose as well as the outcome of between population comparisons.
Background
The assessment of human exposure to environmental
contaminants such as chemical pesticides is often based
on the measurement of metabolites excreted in urine. In
such studies, participants are asked to provide either a
spot sample, multiple spot samples or pooled voids over
timed collection periods (ex: 24 h). Biomarker results can
therefore be expressed in terms of volume-weighted con-
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centrations (μg/L or nmol/L, for example), creatinine-
adjusted concentrations (μg/g of creatinine or μmol/mol
of creatinine), cumulative amounts of metabolite excreted
over specified periods of time, usually 24 h (μg/day or
nmol/day), or hourly excretion rates (ng/h or pmol/h).
All those units can be corrected for the body weight of the
participants.
In the specific case of non-persistent pesticides, namely
pyrethroids and organophosphates (OPs), the determina-
tion of amounts of a biomarker in 24-h urine collections
is generally considered the "benchmark" unit of expres-
sion of biomonitoring results [1-3]. Some authors have
successfully measured cumulative daily amounts or
hourly excretion rates of pyrethroids (μg or nmol/day or
ng or pmol/h) [4-8] and a few others are available in the
case of OP pesticides [6,9-11]. However, it is often
deemed difficult to achieve in some cases due the risk of
incomplete samples, insufficient adherence to the proto-
col and potential attrition among the participants.
Therefore, urinary metabolite levels of these pesticides are
usually reported in volume-weighted concentrations (μg/
L or nmol/L; [12-20]) and/or creatinine-adjusted concen-
trations (μg/g of creatinine; [15,21-24]). Such units are
generally used when participants provide one or more
spot samples. However, the use of spot urine samples has
been questioned in the case of some non-persistent pesti-
cides [25,26].
Volume-weighted concentrations are influenced by urine
dilution, which has been documented to be subject to
important intra- and inter-individual variations due to the
variability in intrinsic and extrinsic factors: liquid intake,
perspiration, humidity level, circadian changes, glomeru-
lar filtration rate, age, disease (e.g., diabetes, lupus), men-
strual cycle, etc. [27-30]. To account for the variations in
urine volume, numerous researchers rely on creatinine
standardization although creatinine levels have also been
reported to be subject to intra- and inter-individual varia-
tions linked to: physical activity, circadian changes, age,
gender, ethnicity, body size, lean-body mass and protein
intake [29,31-36].
Creatinine-adjusted concentrations or volume-weighted
concentrations of pesticide metabolites have been used to
estimate the absorbed daily dose in individuals [37-40].
Creatinine-adjusted concentrations are thus extrapolated
to 24-h excretions using age- and gender-specific default
daily creatinine excretion values taken from the biomedi-
cal literature or using calculated values which also con-
sider height and weight. As for volume-weighted
concentrations, they are converted to 24-h excretions
using age- and gender-specific default daily urine vol-
umes.
Pyrethroids are compounds with relatively short half-lives
and a large fraction, as much as 78%, of an oral dose in
volunteers is excreted as metabolites in urine within 24
hours post-exposure [41]. Therefore, the time of sampling
could influence the outcome of the extrapolation to 24 h,
as in the case of OP pesticides for which it has been
reported that a first morning void should be preferred if
only a spot sample is collected [42]. The influence of the
toxicokinetics of non-persistent pesticides on the choice
of a sampling time frame was more thoroughly discussed
in Barr et al. [26]. However, the influence of the variability
in creatinine excretion rate and urinary flow rate on esti-
mated absorbed doses reconstructed from creatinine-
adjusted concentrations or volume-weighted concentra-
tions has not been systematically assessed in the case of
the non-persistent pyrethroid pesticides.
At the population level, the variability in creatinine excre-
tion rate may also influence results of comparisons of cre-
atinine-adjusted concentrations of biomarkers between
studies while the variability in the urinary flow rate may
affect volume-weighted concentrations. This variability
may have an impact on results of comparisons of biomon-
itoring data between populations, under different units of
measurements, but this has yet to be verified.
The purpose of this study was to determine the relative
impact of the different units of expression of pyrethroid
biomarker data (volume-weighted concentrations, creati-
nine-adjusted concentrations and amounts of metabolite
excreted) i) on estimates of reconstructed absorbed doses
and ii) on results of comparisons of biomonitoring data
between studies while further documenting intra- and
inter-individual variability in creatinine excretion rate and
urinary flow rate.
Methods
Study groups and sample collection
For the determination of the impact of units of expression
of biomarker data on exposure assessment, data from
three pesticide biomonitoring studies were used. Only the
participants who achieved a full collection during the
required period (i.e. did not report urine losses of more
than a few drops) were considered for the present analysis.
All studies were approved by the Human Research Ethics
Committee of the Faculty of Medicine of the Université de
Montréal. Adult participants gave their informed consent
and children gave their assent in addition to the parents
consent.
Study 1 consisted in the biomonitoring of OP exposure in
a group of horticultural greenhouse workers with low
physical workload (n = 15) [9,43]. The workers collected
all their urine during a 24-h period; they provided each
void in a separate bottle and recorded the time of eachEnvironmental Health 2008, 7:55 http://www.ehjournal.net/content/7/1/55
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micturition. Characteristics of the participants are shown
in Table 1.
Study 2 was conducted in the adult and infantile general
population of a large urban and suburban area, the Mon-
treal Island, Quebec, Canada [4]. Adults (n = 74) collected
all their urine during a period of 24 h, in two separate bot-
tles. The first bottle contained the urines voided between
6 pm until the next morning including first urine void on
rising. In the second bottle, all the urines voided follow-
ing the first morning void until 6 pm were cumulated.
Children (n = 74) only carried out the overnight collec-
tion from 6 pm until the next morning including first
morning void (equivalent to the first bottle in adults).
Study 3 was conducted in the adult and infantile general
population of the large rural and agricultural area of the
Montérégie, Quebec, Canada [5]. Adults (n = 109) and
children (n = 42) collected in one bottle all their urine
voided overnight from 6 pm until the next morning
including first void upon waking. Characteristics of the
participants of studies 2 and 3 are depicted in Table 2.
In both studies 2 and 3, subjects were asked to carefully
note the exact time of urine collection (first and last urine
in each bottle) and the time of the last urination prior to
the onset of urine collection. This allows the precise deter-
mination of the accumulation time in the bladder and,
hence, the determination of the urinary flow rate, creati-
nine excretion rate and metabolite excretion rates.
Urine analysis
Samples were analyzed at the Laboratoire de Toxicologie
Humaine of the Institut national de santé publique du Québec.
This public laboratory takes part in an international inter-
laboratory testing program for quality assurance.
Among the different parameters measured and of interest
in the current work, in study 1, it included the measure-
ment of total urine volume and of creatinine contents. In
studies 2 and 3, it included total urine volume and creati-
nine contents as well as the following pyrethroid metabo-
lites: 3-phenoxybenzoic acid (PBA), cis-3-(2,2-
dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid
(cDCCA) and trans-3-(2,2-dichlorovinyl)-2,2-dimethyl-
cyclopropane carboxylic acid (tDCCA). The creatinine
concentration was assessed with a DRI creatinine kit from
Diagnostix Ltd (Mississauga, Canada). The other analyti-
cal methods followed are described in details elsewhere
[4,5,9,43].
Data analysis
Assessment of the variability in the urinary flow rate and creatinine 
excretion rate
Metabolite concentrations (μg/L) depend on urine dilu-
tion and creatinine-adjusted metabolite concentrations
(μg/g of creatinine) depend on creatinine excretion rate.
To assess urine dilution, the urinary flow rate, which cor-
responds to the volume of urine excreted on average per
unit of time (mL/h), was calculated. To evaluate creati-
nine excretion, the average creatinine excretion rate (μg/h)
was computed rather than creatinine concentration
because the latter is influenced by urine dilution. The uri-
nary flow rate and creatinine excretion rate were deter-
mined for each micturition in the case of the participants
of study 1 and for each collection period in the case of the
participants of studies 2 and 3.
From study 1, the void-to-void intra-individual variability
in the urinary flow rate and creatinine excretion rate was
assessed over a 24-h period. For each subject, the follow-
ing descriptive statistics were computed in Microsoft Excel
Table 1: Characteristics of the subjects in study 1
Subject Gender Weight (kg)
Subject 1 Male 75
Subject 2 Male 64
Subject 3 Female 57
Subject 4 Female 48
Subject 5 Female 43
Subject 6 Female 55
Subject 7 Female 50
Subject 8 Male 77
Subject 9 Female 64
Subject10 Female 56
Subject 11 Female 50
Subject 12 Female 68
Subject 13 Male 73
Subject 14 Female 55
Subject 15 Female 57
Table 2: Characteristics of the subjects in studies 2 and 3
Variable Study 2 (Urban) Study 3 (Rural)
Adults Children Adults Children
N 74 74 109 42
Gender
n (%) female 51 (69) 37 (50) 57 (52) 20 (48)
Age (years)
Range 22–63 6–12 18–70 5–12
Median 41 9 48 8
5th, 95th percentiles 26–60 7–12 26–64 6–12
Weight (kg)
Range 38–103 18–61 50–127 15–73
Median 66 32 73 27
5th, 95th percentiles 47–92 22–54 53–106 20–51
Height (m)
Range 1.50–1.93 1.04–1.73 1.47–1.93 1.00–1.73
Median 1.66 1.40 1.68 1.32
5th, 95th percentiles 1.55–1.82 1.15–1.57 1.53–1.84 1.12–1.63Environmental Health 2008, 7:55 http://www.ehjournal.net/content/7/1/55
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(Office 2000, Microsoft corp.): the mean ( ), the mini-
mum (MIN) and maximum (MAX) rates, the maximum
to minimum rate ratio (MAX/MIN), and the coefficient of
variation in rate values (expressed as a percentage
(%CV)).
From studies 2 and 3, the inter-individual variability in
the hourly urinary flow rate and creatinine excretion rate
(established on the basis of nighttime collections) was
evaluated within each study and in both studies com-
bined. In all cases, adults and children were analyzed sep-
arately. Descriptive statistics were computed in Excel ( ,
MIN, 5th and 95th percentiles, MAX, MAX/MIN and %CV).
Distributions of the 12-h volumes and 12-h creatinine
excretion were also established for the adult and infantile
urban and rural populations.
Effect of the variability in the urinary flow rate and creatinine 
excretion rate on individual exposure assessment
Once the variability in the urinary flow rate and creatinine
excretion rate was determined in the studied population
samples, its influence on estimates of reconstructed
absorbed doses from volume-weighted concentrations or
creatinine-adjusted concentrations was assessed. More
specifically, estimates of absorbed doses reconstructed
from biomarker concentrations were calculated for each
individual within each of the studied populations (adult
and children separately and studies 2 and 3 also sepa-
rately). Those concentration-based dose estimates were
compared to doses individually reconstructed from cumu-
lative amounts of pyrethroid metabolites in nighttime
urine collections, which was considered as the "standard"
approach.
Estimation of daily absorbed dose from cumulative amounts of 
metabolite found in nighttime collections
For dose reconstruction, molar amounts of metabolites
excreted during the nighttime collection period (more or
less 15 h) were extrapolated to 24 hours by calculating the
hourly excretion rate (MHER, equation 1) and by multi-
plying its value by 24 and by the molecular weight of per-
methrin (MWp) ((DDCAp) equation 2). The fraction of
absorbed dose recovered in urine as the studied metabo-
lite was not considered for the purpose of comparing con-
centration-based dose estimates with doses reconstructed
from cumulative amounts but this does not have any
impact on the results of comparisons.
The validity of extrapolating nighttime excretions to 24-h
excretions was verified by comparing the hourly excretion
rate calculated on the basis of the nighttime collections to
the hourly excretion rate of metabolites established on the
basis of 24-h collections in one of the studied population
samples (adults of study 1). The comparisons were per-
formed using the non-parametric Wilcoxon test for related
samples and the Spearman correlation test.
Estimation of daily absorbed dose from metabolite volume-weighted 
concentrations in nighttime collections
For dose reconstruction from volume-weighted concen-
trations (DDVWCp), the approach published by Fenske et
al. [37] was followed (equation 3). Daily exposure to per-
methrin was determined from the volume-weighted con-
centrations (μg/L) by multiplying it by age- and gender-
specific estimates of daily urinary volumes taken from the
medical literature [44]. This daily exposure was calculated
for the individuals of each studied population.
Estimation of daily absorbed dose from metabolite creatinine-
adjusted concentrations in nighttime collections
For dose reconstruction from creatinine-adjusted concen-
trations (DDCACp), the approaches published by Fenske
et al. [37] and by Mage et al. [39] were followed (equation
4). Using the method of Fenske et al., daily exposure to
permethrin was estimated by multiplying creatinine-
adjusted concentrations (μg/g of creatinine) by daily cre-
atinine excretions values taken from the medical literature
[45]. Using the method of Mage et al., daily exposure to
permethrin was estimated by multiplying creatinine-
adjusted concentrations (μg/g of creatinine) by daily
amounts of creatinine in urine calculated on the basis of
formulas that account for gender, age, height and weight
differences between participants.
MHER = ([DCCA] × volume)/duration (1)
DDCAp = MHER × 24 h × MWp (2)
DDVWCp = [DCCA] × DUV × MWp (3)
DDCACp = [DCCA]cr × DCE ÷ MWDCCA × MWp (4)
Where: MHER = Metabolite excretion rate
DDCAp = Daily dose of permethrin calculated from cumu-
lative amounts of metabolite in urine (μg/kg bw/day)
DDVWCp = Daily dose of permethrin calculated from vol-
ume-weighted concentration of metabolite in urine (μg/
kg bw/day)
DDCACp = Daily dose of permethrin calculated from cre-
atinine-adjusted concentration of metabolite in urine (μg/
kg bw/day)
[DCCA] = sum of molar concentrations (nmol/L) of the
cDCCA and tDCCA (cis/trans) conformational isomers
x
xEnvironmental Health 2008, 7:55 http://www.ehjournal.net/content/7/1/55
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[DCCA]cr = sum of creatinine-adjusted concentration (μg/
g of creatinine) of cDCCA + tDCCA
volume = total urine volume over the collection period
(L)
duration = time elapse between the last void prior to onset
of collection and the last void collected in the bottle (h)
MWp = Molecular weight of permethrin. Permethrin was
chosen since it appears as one of the main pyrethroids to
which the general population is chronically exposed [4]
(I. Gorse, personal communication].
MWDCCA = Molecular weight of DCCA
DUV = Daily urinary volume (L) taken from the medical
literature [44]
DCE = Daily creatinine excretion (g) taken from the med-
ical literature [45] or predicted from formulas [39]
Effect of variability in the urinary flow rate and creatinine excretion 
rate on the comparison in biomarker values between two populations
The effect of the inter-individual variability in the urinary
flow rate or creatinine excretion rate on results of the com-
parison between two populations of biomarker data
expressed in different units was also assessed. The pyrethroid
metabolite levels between the urban and rural populations
(studies 2 and 3) were compared on the basis of either vol-
ume-weighted concentrations, creatinine-adjusted concen-
tration or, as a reference, excretion rates of pyrethroid
metabolites adjusted for the body weight. A pre-analysis Kol-
mogorov-Smirnov normality test indicated that a non-para-
metric approach should be preferred because the volume-
weighted concentrations, creatinine-adjusted concentrations
and excretion rates of pyrethroid metabolites were not nor-
mally distributed. Comparison of the biomarker data
between the urban and rural populations (adults and chil-
dren separately) was thus performed using the non-paramet-
ric Mann-Whitney U test. Since the purpose of these
comparisons was to assess the impact of the units of expres-
sion of biomarker data on results, samples below the detec-
tion limit were excluded. Differences in urinary flow rates
and creatinine excretion rates between the urban and rural
populations were also assessed using the Student t-test and
Mann-Whitney U test, when the data was normally or not-
normally distributed, respectively.
Results
Variability in the urinary flow rate and creatinine excretion 
rate
Intra-individual variability in urinary flow rate and creatinine excretion 
rate
Table 3 presents the intra-individual variability in the
hourly urinary flow rate and creatinine excretion rate over
a 24-h period, as assessed in the 15 subjects of study 1.
Depending on the participant, the max/min ratio in the
urinary flow rate (hence urine dilution) during a 24-h
period varied between 2.5 and ≈ 18-fold. This corresponds
to a coefficient of variation of 36.1 to 101%. Creatinine
excretion rate was found to be less variable than the uri-
nary flow rate. For a given individual, a 1.1 to 6.6-fold var-
iation (max/min) in the creatinine excretion rate was
observed over a 24-h period. This translates into a coeffi-
cient of variation of up to ≈ 48%.
Table 3: Intra-individual variability in hourly urinary flow rate and creatinine excretion rate over a 24-h period
Urinary flow rate Creatinine excretion rate
Mean
(mL/h)
Min
(mL/h)
Max
(mL/h)
Max
Min
CVa
%
Mean
(g/h)
Min
(g/h)
Max
(g/h)
Max
Min
CVa
%
Subject 1 66.9 38.4 96.5 2.5 36.1 0.074 0.043 0.10 2.4 32.9
Subject 2 67.7 38.4 107 2.8 48.2 0.061 0.055 0.069 1.3 9.66
Subject 3 120 24.9 437 18 101 0.044 0.031 0.051 1.7 13.7
Subject 4 119 57.6 176 3.1 42.3 0.038 0.030 0.047 1.6 14.5
Subject 5 68.8 23.2 123 5.3 57.0 0.027 0.012 0.038 3.2 32.0
Subject 6 46.2 24.7 62.4 2.5 42.0 0.035 0.028 0.044 1.6 24.0
Subject 7 91.0 22.9 185 8.1 77.7 0.034 0.026 0.040 1.5 14.3
Subject 8 53.9 26.9 107 4.0 68.5 0.069 0.065 0.074 1.1 6.06
Subject 9 38.0 20.3 57.3 2.8 40.0 0.052 0.049 0.055 1.1 6.00
Subject10 70.9 25.1 99.0 3.9 42.8 0.037 0.032 0.045 1.4 15.4
Subject 11 49.0 24.0 67.6 2.8 38.8 0.037 0.022 0.047 2.1 31.0
Subject 12 97.9 21.3 168 7.9 58.9 0.033 0.015 0.044 2.9 34.0
Subject 13 50.3 28.3 84.9 3.0 45.7 0.065 0.034 0.082 2.4 27.6
Subject 14 93.4 53.5 167 3.1 54.2 0.055 0.049 0.077 1.6 17.9
Subject 15 98.4 14.6 188 13 59.7 0.037 0.010 0.063 6.6 48.4
aCV = coefficient of variation (standard deviation/mean × 100%)Environmental Health 2008, 7:55 http://www.ehjournal.net/content/7/1/55
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Inter-individual variability in urinary flow rate and creatinine excretion 
rate
Table 4 shows the inter-individual variability in the
hourly urinary flow rate and creatinine excretion rate (cal-
culated on the basis of an overnight collection from 6 pm
until the next morning, including the first void on rising),
as assessed for the infantile and adult urban population
(study 2), rural population (study 3) and both popula-
tions pooled together (studies 2 and 3). In adults, there
was up to an 18-fold inter-individual variation (max/min)
in the hourly urinary flow rate, as compared to a 6.5-fold
variation in children.
On the other hand, in adults, the highest creatinine excre-
tion rate was 9.2 times higher than the smallest rate and
in children there was a 12-fold inter-individual variation
in the creatinine excretion rate, expressed in grams per
hour.
The corresponding variability in total volume and creati-
nine contents in adults and children over a normalized
12-h collection period is also depicted in Figure 1. The dis-
tributions observed in the urban and rural population
were quite similar, except in the case of creatinine excre-
tion in adults (Figure 1b) where the distribution in the
rural population was displaced to the right compared to
the urban population (Mann-Whitney p < 0.001).
Effect of inter-individual variability in the urinary flow rate 
and creatinine excretion rate on individual exposure 
assessment
The impact of the units of expression of urinary biomarker
measurements used to estimate individual absorbed daily
dose of a pyrethroid was assessed in adults and children
of urban and rural populations. It was first determined
that daily urinary amounts of pyrethroid metabolites
could be inferred from amounts in nighttime collections.
The hourly excretion rate of DCCA and PBA in urines col-
lected from 6 pm until the next morning including the
first morning void was not significantly different from uri-
nary metabolite hourly excretion rates calculated on the
basis of 24-h urine collections (Wilcoxon p values = 0.177
for DCCA and 0.381 for PBA). A good correlation was also
observed between the two variables (Spearman rho =
0.925 for DCCA and 0.934 for PBA (p values < 0.001)).
The estimated absorbed daily dose of permethrin recon-
structed from volume-weighted concentrations (as pro-
posed by Fenske et al. [37]) (Table 5) or creatinine-
adjusted concentrations (as proposed by Fenske et al. [37]
and Mage et al. [39]) (Tables 6 and 7) was then compared
to the permethrin daily absorbed dose obtained directly
from cumulative molar amounts of metabolites in over-
night urine collections. In those tables, the data presented
correspond to the estimates for the individuals with uri-
nary flow rates and creatinine excretion rates equal or
closest to the minimum, 5th percentile, median, 95th per-
centile and maximum of their respective population sam-
ple. The absorbed doses of permethrin estimated from
volume-weighted concentrations of DCCA in the adults or
children from the urban or rural area with a median uri-
nary flow rate differed by 0 to 46% from the values calcu-
lated directly from cumulative amounts of biomarker in
urine (Table 5). However, for the individuals with the
lowest urinary output rate, doses reconstructed from vol-
ume-weighted concentrations of DCCA overestimated by
96 to 573%, hence by ≈ 2.0 to 6.7 times, the doses calcu-
lated from cumulative urinary amounts of biomarker. For
Table 4: Inter-individual variability in hourly urinary flow and creatinine excretion rates calculated from nocturnal urine collections
Urinary flow rate Creatinine excretion rate
Mean
(mL/h)
Range
(Min-Max)
(mL/h)
Percentiles (5–95th)
(mL/h)
Max
Min
CVa
%
Mean
(mL/h)
Range
(Min-Max)
(mL/h)
Percentiles (5–95th)
(mL/h)
Max
Min
CVa
%
Adults
Urban
(n = 74)
59.8 7.21–133 21.8–113 18 47.1 0.049 0.016–0.10 0.019–0.084 6.7 36.4
Rural
(n = 109)
63.4 20.6–127 29.7–108 6.2 38.7 0.062 0.020–0.14 0.034–0.10 7.1 35.6
Both
(n = 183)
62.0 7.21–133 26.4–112 18 42.1 0.057 0.016–0.14 0.029–0.095 9.2 37.4
Children
Urban
(n = 74)
32.0 10.7–69.5 13.4–61.9 6.5 48.0 0.027 0.011–0.082 0.014–0.045 7.7 42.1
Rural
(n = 42)
26.6 10.8–64.6 14.3–48.7 6.0 45.9 0.025 0.0071–0.065 0.013–0.042 9.1 44.6
Both
(n = 116)
30.1 10.7–69.5 13.6–61.4 6.5 48.2 0.026 0.0071–0.082 0.014–0.045 12 43.1
aCV = coefficient of variation (standard deviation/mean × 100%)Environmental Health 2008, 7:55 http://www.ehjournal.net/content/7/1/55
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the participants with the highest urinary flow rate, doses
reconstructed from concentrations underestimated by 39
to 70%, hence by about 0.3 to 0.6 times, the values
obtained from cumulative amounts. Correspondingly,
when considering the 5 and 95th percentile of urinary flow
rates instead of the minimum and maximum values, an
overestimation of 160% and an underestimation of 55%
were calculated.
The absorbed doses of permethrin estimated from creati-
nine-adjusted concentrations (method of Fenske et al.
[37]) of DCCA in adults and children of the urban or rural
population with median creatinine excretion rates dif-
fered by -44% to +23% from the doses calculated directly
from cumulative urinary amounts (Table 6). For the par-
ticipants with creatinine excretion rates closest to the 5th
and 95th percentiles of their population sample, the error
ranged from -39% to +112%. For the participants with the
lowest creatinine excretion rate, doses reconstructed from
creatinine-adjusted concentrations overestimated by 94 to
167%, hence by 2 to 3 times, the doses calculated directly
from cumulative urinary amounts of biomarker. For the
individuals with the highest creatinine excretion rate,
doses reconstructed from creatinine-adjusted concentra-
tions underestimated by 32% to more than 83%, hence by
0.2 to 0.7 times, the values obtained from cumulative
amounts. With a more refined approach published by
Mage et al. [39] for dose reconstruction based on creati-
nine-adjusted concentrations that takes into account the
height of the subjects in addition to their weight and age,
the estimates of absorbed dose were slightly closer to the
values calculated from cumulative amounts of biomarker
Urine volumes (mL/12 h) and creatinine amounts (g/12 h) in adults and children from urban (h) and rural (￿) populations Figure 1
Urine volumes (mL/12 h) and creatinine amounts (g/12 h) in adults and children from urban (h) and rural (•) 
populations.
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(Table 7), ranging from -63% to +93% of the actual
amounts in the case of adults and from -61% to +187% in
the case of children.
Effect of inter-individual variability in the urinary flow rate 
and creatinine excretion rate on the comparison of 
biomarker values between two populations
Table 8 shows the effect of the units of measurements
(volume-weighted or creatinine adjusted concentrations)
on results of the comparison of pyrethroid biomarker lev-
els between two populations (urban versus rural). These
results were compared to the reference ones obtained
when assessing the difference between the two popula-
tions in hourly excretion rate values of pyrethroid metab-
olites normalized per unit of body weight (μg/h/kg bw).
Comparison conducted on the basis of volume-weighted
concentrations of DCCA or PBA lead to results similar to
those obtained on the basis of excretion rates of these
metabolites.
Table 5: Absorbed permethrin dose estimated from volume-weighted concentrations (V) and amounts (A) of DCCA
Permethrin absorbed dose
Relative urinary flow rate (A) Estimated from cumulative amounts (μg/kg 
bw/day)
(V) Estimated from volume-weighted 
concentrationsa (μg/kg bw/day)
V/A
Adults
Urban
Lowestb 0.00354 0.0238 6.7
5th percentilec 0.0564 0.134 2.4
Mediand 0.00941 0.0137 1.5
95th percentilee 0.00571 0.00390 0.6
8
Highestf 0.0304 0.0111 0.3
7
Rural
Lowestb 0.00143 0.00337 2.4
5th percentilec 0.0113 0.0295 2.6
Mediand 0.00573 0.00725 1.3
95th percentilee 0.00241 0.00108 0.4
5
Highestf 0.0203 0.0123 0.6
1
Children
Urban
Lowestb 0.0185 0.0365 2.0
5th percentilec 0.00551 0.00833 1.5
Mediand 0.00537 0.00621 1.2
95th percentilee 0.0310 0.0170 0.5
5
Highestf 0.0258 0.00780 0.3
0
Rural
Lowestb 0.00481 0.00941 2.0
5th percentilec 0.104 0.222 2.1
Mediand 0.00966 0.00970 1.0
95th percentilee 0.0183 0.0115 0.6
3
Highestf 0.0188 0.00980 0.5
2
aCalculated according to the method of Fenske et al. [37]
bAbsorbed dose estimates for the participant with the lowest urinary flow rate
cAbsorbed dose estimates for the participant with the urinary flow rate closest to the 5th percentile value
dAbsorbed dose estimates for the participants with the median urinary flow rate
eAbsorbed dose estimates for the participant with the urinary flow rate closest to the 95th percentile value
fAbsorbed dose estimates for the participant with the highest urinary flow rateEnvironmental Health 2008, 7:55 http://www.ehjournal.net/content/7/1/55
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Comparison of pyrethroid levels between the urban and
rural adult population on the basis of creatinine-adjusted
DCCA and PBA concentrations lead to more divergent
results. In particular, a non significant difference in PBA
creatinine-adjusted concentrations was observed between
the two groups contrary to what was observed on the basis
of PBA excretion rates or volume-weighted concentra-
tions. It was observed that the rural adult population had
a significantly higher creatinine excretion rate than the
urban population (p < 0.001), which may have biased the
test, whereas the distribution of the urinary flow rate was
similar between the two groups (p = 0.357). In children,
no significant difference in either the urinary flow rate or
creatinine excretion rate was observed between the urban
and rural population (p = 0.081 and 0.160, respectively).
Discussion
The purpose of this research was to document the intra-
and inter-individual variability in creatinine excretion rate
and urinary flow rate in order to determine the relative
impact of the different units of expression of pyrethroid
biomarker data i) on reconstructed absorbed doses in
individuals and ii) on results of comparisons of popula-
tion biomonitoring data. This led to identify the most
suitable units of expression of biomonitoring data and
straightforward strategies for data collection in the case of
non-persistent pesticides such as pyrethroids.
Intra-individual day-to-day variations in daily creatinine
excretion (g/day) have been well documented [46,47]
but, to our knowledge, this is the first report of between-
void variability in creatinine excretion rate and urinary
flow rate during the course of a day. In an assessment of
intra-individual day-to-day variations in creatinine excre-
tion rate in 24-h urine collections based on several stud-
ies, Garde et al. [48] reported a coefficient of variation of
9–24%. However, void-to-void variations in creatinine
excretion rate were not studied. Our findings demonstrate
Table 6: Absorbed permethrin dose estimated from creatinine-adjusted concentrations (C1) and amounts (A) of DCCA
Permethrin absorbed dose
Relative creatinine excretion rate (A) Estimated from cumulative amounts 
(μg/kg bw/day)
(C1) Estimated from creatinine-adjusted 
concentrationsa (μg/kg bw/day)
C1/A
Adults
Urban
Lowestb 0.00625 0.0167 2.7
5th percentilec 0.00749 0.0159 2.1
Mediand 0.835 0.739 0.89
95th percentilee 0.0153 0.0131 0.86
Highestf 0.00912 0.00622 0.68
Rural
Lowestb 0.0164 0.0340 2.1
5th percentilec 0.0136 0.0167 1.2
Mediand 0.0155 0.0191 1.2
95th percentilee 0.0104 0.00722 0.69
Highestf 0.0286 0.0142 0.50
Children
Urban
Lowestb 0.0185 0.0469 2.5
5th percentilec 0.177 0.342 1.9
Mediand 0.0120 0.00667 0.56
95th percentilee 0.00754 0.00461 0.61
Highestf 0.0818 0.0137 0.17
Rural
Lowestb 0.00481 0.00932 1.9
5th percentilec 0.00631 0.00670 1.1
Mediand 0.0155 0.0189 1.2
95th percentilee 0.0237 0.0153 0.65
Highestf 0.0188 0.00786 0.42
aCalculated according to the method of Fenske et al. [37]
bAbsorbed dose estimates for the participant with the lowest creatinine excretion rate
cAbsorbed dose estimates for the participant with the creatinine excretion rate closest to the 5th percentile value
dAbsorbed dose estimates for the participants with the median creatinine excretion rate
eAbsorbed dose estimates for the participant with the creatinine excretion rate closest to the 95th percentile value
fAbsorbed dose estimates for the participant with the highest creatinine excretion rateEnvironmental Health 2008, 7:55 http://www.ehjournal.net/content/7/1/55
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an important intra-individual variability in both the uri-
nary flow rate (CV of 36.1 to 101%; max/min ratio of up
to 18 fold) and creatinine excretion rate (CV of 6.0 to
48.4%; max/min ratio of up to 6.6. fold) during the
course of a day in adults, the latter being larger than the
day-to-day variations reported by Garde et al. [48]. Those
variations are likely the consequence of fluid intake for
the former and dietary protein intake [36] and physical
activity [49] for the latter. It has also been reported that
variations in the urinary flow rate may explain as much as
21% of the creatinine variability [50], although this find-
ing has been disputed. Our results suggest that there could
be a difference of nearly a factor seven in creatinine-
adjusted concentrations of a metabolite measured in two
different urine samples taken the same day from a same
individual solely due to the intra-individual intra-day var-
iation in creatinine excretion rate.
Inter-individual variability in the urinary output and cre-
atinine excretion rate has also been extensively studied;
factors influencing these variations include age, gender,
ethnicity, fat-free mass and height, ambient temperature,
physical activity [31,51,52]. Garde et al. [48] reported
coefficient of variations for inter-individual variations in
creatinine excretion rate in 24-h urine collections ranging
from 17–25%. In our study, using a shorter urine collec-
tion period (over a ± 12-h nighttime collection), inter-
individual variability in the urinary flow rate and creati-
nine excretion rate was further evaluated in 183 adults
and 116 children from urban and rural areas. Creatinine
Table 7: Absorbed permethrin dose estimated from creatinine-adjusted concentrations (C2) and amounts (A) of DCCA
Permethrin absorbed dose
Relative creatinine excretion rate (A) Estimated from cumulative amounts 
(μg/kg bw/day)
(C2) Estimated from creatinine-adjusted 
concentrationsa (μg/kg bw/day)
C2/A
Adults
Urban
Lowestb 0.00625 0.0120 1.9
5th percentilec 0.00749 0.0145 1.9
Mediand 0.835 0.807 0.97
95th percentilee 0.0153 0.0136 0.89
Highestf 0.00912 0.00716 0.79
Rural
Lowestb 0.0164 0.0313 1.9
5th percentilec 0.0136 0.0155 1.1
Mediand 0.0155 0.0170 1.1
95th percentilee 0.0104 0.00730g 0.73
Highestf 0.0286 0.0103g 0.36
Children
Urban
Lowestb 0.0185 0.0256 1.4
5th percentilec 0.177 0.5103 2.9
Mediand 0.0120 0.0113 0.94
95th percentilee 0.00754 0.00465 0.62
Highestf 0.0818 0.0315 0.39
Rural
Lowestb 0.00481 0.00674 1.4
5th percentilec 0.00631 0.00650 1.0
Mediand 0.0155 0.0144 0.93
95th percentilee 0.0237 0.0176 0.74
Highestf 0.0188 0.0158 0.84
aCalculated according to the method of Mage et al. [42]
bAbsorbed dose estimates for the participant with the lowest creatinine excretion rate
cAbsorbed dose estimates for the participant with the creatinine excretion rate closest to the 5th percentile value
dAbsorbed dose estimates for the participants with the median creatinine excretion rate
eAbsorbed dose estimates for the participant with the creatinine excretion rate closest to the 95th percentile value
fAbsorbed dose estimates for the participant with the highest creatinine excretion rate
gThis individual was obese (BMI > 30.0) and, in this specific case, Mage et al. [42] suggest to use lean body mass for the prediction of creatinine 
excretionEnvironmental Health 2008, 7:55 http://www.ehjournal.net/content/7/1/55
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excretion rate was found to be almost as variable (CV of
35.6 to 44.6%) as the urine volume (CV of 38.7–48.2%).
This corresponds to a possible 9-fold (in adults) or 12-
fold (in children) variation in the creatinine-adjusted con-
centrations of a metabolite solely due to the inter-individ-
ual variability in the creatinine-excretion rate. For urinary
output, it implies that, if all adults absorbed the same
dose of parent-compound, one could observe an 18-fold
variation in metabolite concentrations solely due to inter-
individual variations in the urine dilution. In children, the
ratio between the more diluted and the more concen-
trated urines was about 6.
Results of our study show that variability in creatinine
excretion and urinary output will directly influence the
estimates of reconstructed absorbed dose of pyrethroids
in an individual conducted on the basis of the volume-
weighted or creatinine-adjusted concentrations of
biomarkers. In 2007, Mage et al. [39] proposed a formula
to predict daily creatinine excretion to estimate pesticide
daily absorbed doses from creatinine-adjusted concentra-
tions of metabolites in spot urine samples while account-
ing for inter-individual differences in age, gender, height
and weight. Although this latter approach yields results
closer to the cumulative amounts directly measured in
urine than the approach used by Fenske et al. [37], it is
nonetheless not very precise for individuals with marginal
creatinine excretions (high or low), or atypical creatinine
excretion (i.e. urinary creatinine excretion not well pre-
dicted by the formula), as observed in our study. In fact,
errors in dose estimates based on creatinine-adjusted or
volume-weighted concentrations can reach 500% or more
in some cases.
It is to be noted that, in our estimation of the absorbed
dose, the fraction of the dose recovered in urine as metab-
olites was not considered in dose reconstruction. This had
no effect on our comparison of the different approaches
for dose reconstruction but absolutely needs to be consid-
ered for accurate dose reconstruction and comparison
with acceptable daily intakes.
With regard to the comparison of pyrethroid metabolite
levels between two populations however, volume-
weighted concentrations gave similar results to those
obtained on the basis of cumulative amounts while dis-
crepancies were observed between creatinine-adjusted
concentrations and hourly excretion rates of some pyre-
throid metabolites. When the urinary flow rates or creati-
nine excretion rates are normally distributed and not
significantly different from one population to the other,
comparison of metabolite levels between two populations
may give similar results whatever the unit of measurement
(volume-weighted concentration, creatinine-adjusted
concentration or cumulative amounts). Conversely, if a
significant difference in the urinary output or in the creat-
inine excretion rate is observed, then discrepancies in the
comparison results may be observed depending on the
units of measurements.
For instance, adults from the rural population were heav-
ier than the urban adults, and possibly more physically
active, which may have affected their creatinine excretion
rate, hence results of comparisons of creatinine-adjusted
concentrations of metabolites between the two popula-
tion samples. In another context, if one would compare
concentrations of a pyrethroid metabolite in an Asian
population to those of North-Americans on the basis of
creatinine-adjusted values, significant differences could
emerge due to variations in creatinine excretion rate as a
result of differences in muscular mass between the two
populations (higher stature of North-Americans com-
pared to Asians). Barr et al. [31] described in details the
factors influencing inter-individual creatinine variability
in the US population and analyzed the influence of differ-
ent factors, including ethnicity, gender and age, with a
multiple linear regression model. They then stratified cre-
atinine concentrations in their population (n = 22 245,
Table 8: Mann-Whitney comparisons of metabolite levels, expressed in different units, between urban and rural populations
Population and metabolite 
assessed
Statistical significance (p value) of comparisons between the urban and rural population
Comparison of weight-adjusted 
excretion rates (nmol/kg bw/h)
Comparison of volume-weighted 
concentrations (nmol/L)
Comparison of creatinine-adjusted 
concentrations (μmol/mol of 
creatinine)
Adults
DCCA 0.128 0.139 0.465
PBA 0.016* 0.010* 0.093
Children
DCCA 0.032* 0.042* 0.029*
PBA 0.027* 0.023* 0.023*
*Indicates a significant differenceEnvironmental Health 2008, 7:55 http://www.ehjournal.net/content/7/1/55
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NHANES) according to these factors, thus providing refer-
ence values for different subgroups of the US population.
The application of the regression model elaborated by
Barr et al. [31] in such a context might not be adequate
since the coefficients were derived for people of different
races, but living more or less in the same environment.
Therefore, to verify adequately that there is no bias in the
results of comparisons of exposure levels assessed on the
basis of volume-weighted or creatinine-adjusted concen-
trations between populations from different countries,
one also needs to verify if there is a significant difference
in the urinary flow rate or in the creatinine excretion rate,
which requires timed collections. With timed-collections,
metabolite excretion rate adjusted for the body weight can
be directly determined and used for comparison of expo-
sure between two populations instead of volume-
weighted or creatinine-adjusted concentrations.
Conclusion
Overall, although it is more practical in field studies to
determine concentrations of non-persistent pesticide
metabolites in spot urine samples and adjust for creati-
nine contents, our results show that it may lead to serious
errors in the estimation of the actual daily absorbed doses,
particularly at the individual level. For a more accurate
assessment of individual absorbed doses, we conclude
that it is better to determine total amounts of metabolites
in urine collected over the longest feasible and practical
period of time. Collection of overnight urine voids (6 pm
to first morning void) limits the risk of urine loss and par-
ticipant attrition that increases with longer urine collec-
tion periods and allows a valid assessment of the 24-h
excretion rate of pyrethroid metabolites.
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